First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18

BACKGROUND: This is the first clinical trial in the global pediatric clinical development program for the use of the analgesic tapentadol in children and adolescents. PATIENTS AND METHODS: This multicenter, open-label clinical trial investigated pharmacokinetics, safety and tolerability, and efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Finkel, Julia C, Goldberg, Jutta, Rosenburg, Ronald, Ariyawansa, Jay, Sun, Tao, Ochs-Ross, Rachel, Zannikos, Peter, Zhang, Liping, Etropolski, Mila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610295/
https://www.ncbi.nlm.nih.gov/pubmed/31303784
http://dx.doi.org/10.2147/JPR.S197348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610295/
https://www.ncbi.nlm.nih.gov/pubmed/31303784
http://dx.doi.org/10.2147/JPR.S197348

Ejemplares similares